July 26, 2016 11:48 AM ET


Company Overview of Ardelyx, Inc.

Key Executives for Ardelyx, Inc.

NameBoard RelationshipsTitleAge
Michael G. Raab 28 RelationshipsChief Executive Officer, President and Director51
Mark E. Kaufmann MBA5 RelationshipsChief Financial Officer and Principal Accounting Officer48
Jeremy S. Caldwell Ph.D.5 RelationshipsChief Scientific Officer and Executive Vice President47
Elizabeth A. Grammer Esq.No RelationshipsSenior Vice President and General Counsel 52
Paul Korner M.D., M.B.A.No RelationshipsChief Medical Officer and Executive Vice President50
View More Key Executives

Ardelyx, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David M. Mott NEA 188 RelationshipsMersana Therapeutics, Inc.51
Michael G. Raab 28 RelationshipsArdelyx, Inc.51
Richard J. Rodgers 24 RelationshipsArdelyx, Inc.49
Gordon Ringold Ph.D. 26 RelationshipsAlavita Pharmaceuticals Inc.65
Annalisa Jenkins MBBS, MRCP 84 RelationshipsDimension Therapeutics, Inc.51
View All Board Members

Ardelyx, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Richard J. Rodgers24 Relationships3 Executives
Compensation Committee NEADavid M. Mott188 Relationships3 Executives
Nominating Committee Ph.D.Gordon Ringold26 Relationships2 Executives
Corporate Governance Committee Ph.D.Gordon Ringold26 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$470.0K
Total Value of Options
Compensation as of Fiscal Year
Ardelyx, Inc. CEO Compensation
Industry Average


Announces Executive Appointments
July 26, 2016 6:00 AM ET
Acceleron Pharma Inc. Appoints Thomas McCourt to its Board of Directors
July 25, 2016 8:05 PM ET
EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations
July 25, 2016 3:32 PM ET
VBI Vaccines Inc. Vaccines Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer
July 25, 2016 12:30 PM ET
Cleveland BioLabs, Inc. Announces Executive Changes
July 22, 2016 8:22 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ardelyx, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.